Xing J, Wang Y, Cao M, Shan F, et al. Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forests. Eur J Surg Oncol 2025;51:109752.
PMID: 40544664